Cetuximab Completed Phase 2 Trials for Liver Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00483405Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer